Véronique Lecault
Founder bij ABCELLERA BIOLOGICS INC.
Vermogen: 48 M $ op 29-02-2024
Profiel
Dr. Vronique Lecault is Vice President bij Lineage Biosciences, Inc. en Chief Operating Officer & Director bij AbCellera Biologics, Inc. Zij zetelt in de Raad van Bestuur van Trianni, Inc., Channel Biologics Pty Ltd. en AbCellera Biologics, Inc. Zij behaalde haar doctoraatsdiploma aan de Universiteit van Ottawa en haar doctoraatsdiploma aan de Universiteit van British Columbia.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
14-01-2024 | 9 530 340 ( 3.26% ) | 48 M $ | 29-02-2024 |
Actieve functies van Véronique Lecault
Bedrijven | Functie | Begin |
---|---|---|
ABCELLERA BIOLOGICS INC. | Founder | 08-11-2012 |
Lineage Biosciences, Inc.
Lineage Biosciences, Inc. Hospital/Nursing ManagementHealth Services Lineage Biosciences, Inc. engages in biotechnology services. The company was founded on May 30, 2014 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | 01-01-2018 |
AbCellera Australia Pty Ltd. | Director/Board Member | 01-09-2019 |
Trianni, Inc.
Trianni, Inc. BiotechnologyHealth Technology TRIANNI, Inc. operates as a biotech company. It specializes in antibody discovery technology using transgenic mice. Its Trianni Mouse platform enables the generation of fully-human monoclonal antibodies. The company was founded in 2010 and is headquartered in San Francisco, CA. | Director/Board Member | 01-11-2020 |
Opleiding van Véronique Lecault
University of British Columbia | Doctorate Degree |
University of Ottawa | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ABCELLERA BIOLOGICS INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Trianni, Inc.
Trianni, Inc. BiotechnologyHealth Technology TRIANNI, Inc. operates as a biotech company. It specializes in antibody discovery technology using transgenic mice. Its Trianni Mouse platform enables the generation of fully-human monoclonal antibodies. The company was founded in 2010 and is headquartered in San Francisco, CA. | Health Technology |
Lineage Biosciences, Inc.
Lineage Biosciences, Inc. Hospital/Nursing ManagementHealth Services Lineage Biosciences, Inc. engages in biotechnology services. The company was founded on May 30, 2014 and is headquartered in Vancouver, Canada. | Health Services |
AbCellera Australia Pty Ltd. |